| scholarly article | Q13442814 |
| P50 | author | Leonid O. Kononov | Q43750952 |
| Gennady Burygin | Q80851808 | ||
| Lev Dykman | Q91794615 | ||
| P2093 | author name string | Sergey A Staroverov | |
| Nikita M Podvalnyy | |||
| Polina I Abronina | |||
| P2860 | cites work | Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria | Q26765815 |
| Structural insights into antibody recognition of mycobacterial polysaccharides | Q27656319 | ||
| Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology | Q29617209 | ||
| Tuberculosis in New York city: recent lessons and a look ahead. | Q30341421 | ||
| Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies. | Q30792206 | ||
| The use of immunological methods to detect and identify bacteria in the environment | Q31009116 | ||
| Gold-ligand interaction studies of water-soluble aminoalcohol capped gold nanoparticles by NMR. | Q31158995 | ||
| Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers | Q33362786 | ||
| Immunological properties of gold nanoparticles | Q33578950 | ||
| Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers | Q33819711 | ||
| Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). | Q33960731 | ||
| The world-wide increase in tuberculosis: how demographic changes, HIV infection and increasing numbers in poverty are increasing tuberculosis | Q34212054 | ||
| Rational design and synthesis of optimized glycoclusters for multivalent lectin-carbohydrate interactions: influence of the linker arm. | Q34226384 | ||
| A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei | Q35088366 | ||
| Synthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine Candidates | Q35212122 | ||
| Multivalent glycoconjugates as anti-pathogenic agents | Q35444698 | ||
| Review: multidrug-resistant tuberculosis: public health challenges | Q35631580 | ||
| Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse | Q35685656 | ||
| Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines | Q36200540 | ||
| Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model | Q36202229 | ||
| Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science | Q36418242 | ||
| A Fully Synthetic Self-Adjuvanting Globo H-Based Vaccine Elicited Strong T Cell-Mediated Antitumor Immunity. | Q36604334 | ||
| Clustered carbohydrates in synthetic vaccines | Q36844110 | ||
| Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis | Q36850638 | ||
| Twenty Years of Mycobacterial Glycans: Furanosides and Beyond | Q37113880 | ||
| Immunotherapy for cancer: synthetic carbohydrate-based vaccines | Q37453814 | ||
| Recent development in carbohydrate-based cancer vaccines | Q37455940 | ||
| Design and creativity in synthesis of multivalent neoglycoconjugates | Q37728426 | ||
| Glyconanoparticles: multifunctional nanomaterials for biomedical applications. | Q37775971 | ||
| Glyconanoparticles polyvalent tools to study carbohydrate-based interactions | Q37788384 | ||
| Gold nanoparticles in biomedical applications: recent advances and perspectives | Q37963225 | ||
| Glyconanoparticles as multifunctional and multimodal carbohydrate systems. | Q38071545 | ||
| Glyconanotechnology | Q38072859 | ||
| Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology | Q38083759 | ||
| A guide into glycosciences: How chemistry, biochemistry and biology cooperate to crack the sugar code. | Q38200769 | ||
| Glycomimetics versus multivalent glycoconjugates for the design of high affinity lectin ligands | Q38286204 | ||
| Advances in multifunctional glycosylated nanomaterials: preparation and applications in glycoscience | Q38286649 | ||
| Design and Synthesis of Galactosylated Bifurcated Ligands with Nanomolar Affinity for Lectin LecA from Pseudomonas aeruginosa | Q38288646 | ||
| Toward the Rational Design of Galactosylated Glycoclusters That Target Pseudomonas aeruginosa Lectin A (LecA): Influence of Linker Arms That Lead to Low-Nanomolar Multivalent Ligands | Q38291727 | ||
| Importance of topology for glycocluster binding to Pseudomonas aeruginosa and Burkholderia ambifaria bacterial lectins | Q38296311 | ||
| Influence of ligand presentation density on the molecular recognition of mannose-functionalised glyconanoparticles by bacterial lectin BC2L-A. | Q38315565 | ||
| Gold nanoparticles and vaccine development. | Q38543673 | ||
| Glyco-gold nanoparticles: synthesis and applications | Q39419658 | ||
| Gold glyconanoparticles as new tools in antiadhesive therapy. | Q40582925 | ||
| Identification serologically, chemically and genetically of two Escherichia coli strains as candidates for new O serogroups | Q40618234 | ||
| Gold Nanoparticles Decorated with Sialic Acid Terminated Bi-antennary N-Glycans for the Detection of Influenza Virus at Nanomolar Concentrations | Q40698707 | ||
| Synthesis and Evaluation of GM2-Monophosphoryl Lipid A Conjugate as a Fully Synthetic Self-Adjuvant Cancer Vaccine. | Q41194257 | ||
| Synthetic and Immunological Studies of sTn Derivatives Carrying 5-N-(p-Substituted Phenylacetyl)Sialic Acid for the Development of Effective Cancer Vaccines | Q41809862 | ||
| 'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines. | Q41965469 | ||
| Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide | Q43094784 | ||
| TBCAP; tuberculosis annotation project | Q43635380 | ||
| Polarimetry as a tool for the study of solutions of chiral solutes | Q46345826 | ||
| Synthesis and Characterization of Hapten-Protein Conjugates for Antibody Production against Cyanogenic Glycosides | Q46771014 | ||
| Gold nanoparticles as an adjuvant: Influence of size, shape, and technique of combination with CpG on antibody production | Q47176241 | ||
| Size-optimized galactose-capped gold nanoparticles for the colorimetric detection of heat-labile enterotoxin at nanomolar concentrations | Q47395136 | ||
| Recent applications of click chemistry for the functionalization of gold nanoparticles and their conversion to glyco-gold nanoparticles | Q48146455 | ||
| A new method for producing a specific and high titre antibody against glutamate using colloidal gold as a carrier | Q48298962 | ||
| Synthesis and Immunological Comparison of Differently Linked Lipoarabinomannan Oligosaccharide-Monophosphoryl Lipid A Conjugates as Antituberculosis Vaccines. | Q48348863 | ||
| Significance of Nanoparticles and the Role of Amino Acids in Structuring Them-A Review | Q49838484 | ||
| Stereoselective sialylation with O-trifluoroacetylated thiosialosides: hydrogen bonding involved? | Q49961076 | ||
| Synthetic and Immunological Studies of Mycobacterial Lipoarabinomannan Oligosaccharides and Their Protein Conjugates. | Q50934977 | ||
| Effect of anchoring groups on single-molecule conductance: comparative study of thiol-, amine-, and carboxylic-acid-terminated molecules. | Q51097771 | ||
| Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines | Q57187124 | ||
| The use of the novel glycosyl acceptor and supramer analysis in the synthesis of sialyl-α(2-3)-galactose building block | Q57816467 | ||
| Polyacrylamide-based glycoconjugates as tools in glycobiology | Q77768611 | ||
| Preparation and stabilization of monodisperse colloidal gold by reduction with aminodextran | Q83778832 | ||
| Use of ELISA with antiexopolysaccharide antibodies to evaluate wheat-root colonization by the rhizobacterium Paenibacillus polymyxa | Q83912285 | ||
| Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles | Q85511798 | ||
| Gold nanoparticles with different amino acid surfaces: serum albumin adsorption, intracellular uptake and cytotoxicity | Q86169179 | ||
| Opportunities for glyconanomaterials in personalized medicine | Q88493838 | ||
| Application of a Janus aglycon with dual function in benzyl-free synthesis of spacer-armed oligosaccharide fragments of polysaccharides from rhizobacterium Azospirillum brasilense sp7 | Q88872261 | ||
| Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine | Q95812278 | ||
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 480-493 | |
| P577 | publication date | 2020-03-19 | |
| P1433 | published in | Beilstein Journal of Nanotechnology | Q814756 |
| P1476 | title | Preparation and in vivo evaluation of glyco-gold nanoparticles carrying synthetic mycobacterial hexaarabinofuranoside | |
| P478 | volume | 11 |
| Q92047320 | Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases | cites work | P2860 |
Search more.